Dr. Mark & David Geier Research

[Required for PDF files]

NOTE: All files open in new browser window. Please disable popup blockers.

1. RotaTeq vaccine adverse events and policy considerations (PDF 728K)
   David A. Geier, Paul G. King, Lisa K. Sykes, Mark R. Geier
    

2. A prospective assessment of androgen levels in patients with autistic spectrum disorders:
   biochemical underpinnings and suggested therapies (PDF 259K)
   David A. Geier & Mark R. Geier
    
3. A Review of Thimerosal (Merthiolate) and its Ethylmercury Breakdown Product: Specific Historical Considerations Regarding Safety and Effectiveness. (PDF 201k)
   David A. Geier; Lisa K. Sykes; Mark R. Geier
    
4. A Prospective Study of Mercury Toxicity Biomarkers in Autistic Spectrum Disorders (PDF 359k)
   SUMMARY
   Porphyrins are derivatives formed in the heme synthesis pathway and porphyrins afford a measure of xenobiotic exposure.  Porphyrins need to be routinely measured in ASDs to establish if mercury toxicity is a causative factor and to evaluate the effectiveness of chelation therapy.
    
5. Neurodevelopmental Disorders After Thimerosal-Containing Vaccines - A Brief Communication
   (PDF 63k)
   ** VAERS Database
    
6. A Comparative Evaluation of the Effects of MMR Immunization and Thimerosal on the Population Prevalence of Autism (PDF 98k)
   ** US Department of Education - Ecological Study
    
7. A Meta-Analysis Study (PDF 173k)
   ** VAERS Database
    
8. A Prospective Study of Rho Immune Globulin as a Risk Factor for Autism1 (PDF 86k)
   ** Assessment of Autism Clinic Database - Case-Control Study
    
9. A Two-Phased Population Epidemiological Study of the Safety of Thimerosal-Containing Vaccines
   (PDF 140k)
   ** VAERS & VSD Databases
    
10. An Assessment of Downward Trends Following Thimerosal Removal (PDF 206k)
    ** VAERS Database - Ecological Study
     
11. An Assessment of the Impact of Thimerosal on Childhood Neurodevelopmental Disorders (PDF 100k)
    ** VAERS Database
    US Department of Education - Ecological Study
     
12. An Evaluation of the Effects of Thimerosal on NDs (PDF 101k)
    ** VAERS Database
     
13. Early Downward Trends in NDs Following Removal of Thimerosal (PDF 350k)
    ** VAERS Database, California Department of Developmental Services, & US Department of Education - Ecological Study
     
14. NeuroDevelopmental Disorders Following TCVs - A Follow-up Analysis (PDF 177k)
    ** VAERS Database
     
15. Thimerosal in Childhood Vaccines - Neurodevelopmental Disorders - Heart Disease in the United States (PDF 155k)
    ** VAERS Database
    US Department of Education - Ecological Study
    VSD Database (review of early Verstraeten documents)
     
16. A Case-Control Study of Mercury Burden in Children with Autistic Spectrum Disorders (PDF 223k)
     
17. Porphyrins in Autistic Disorders (PDF 537k)
     
18. A Case-Series of Children with Mercury Toxic Encephalopathies (PDF 153k)
     
19. Published Hormone Research Article 2006 (PDF 136k)
     
20. Published Mercury and Testosterone Medical Hypothesis (PDF 160k)
     
21. Evolving views on the causes of autistic spectrum disorders (PDF 51k)
     
22. Response to Critics (PDF 86k)
     
23. Thimerosal Does Not Belong in Vaccines (PDF 69k)
     
24. Study Misses Link Between Thimerosal and Neurodevelopmental Disorders (PDF 23k)
     
25. Geier and Geier Lancet Published Letter (PDF 76k)
     
26. Parents Fears About Thimerosal (PDF 71k)
     
27. Response to Comments by JR Mann (PDF 35k)